Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Open Innovation for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Partneringtools
Reports
Partnering Consulting
Due Diligence
Comparison
 
Due Diligence
Overview
Top Applications
Online Panel Discussions
Request Consultation
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
Forums
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing Ltd
is a division of
UTEK Corporation
Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..10 of 15 - per page Next page
Order by
Cripto-1 expression increases the expression of TNF-alpha in CD4+ T cells in tissues affected by chronic inflammatory disease. More
Diagnostic assay for early detection of nephropathy related to diabetes and other nephropathy-associated disorders. More
Diagnostic and potential therapeutic applications for mucin gene 4 (MUC4). More
Acetaminophen-protein Adduct Dipstick: rapid, sensitive and specific diagnostic device for point-of-care determination of acetaminophen toxicity More
Unique proangiogenic biomarkers isolated from ovarian endothelial cells More
Through in vitro and in vivo tumor suppression experiments, the inventors have demonstrated that DLC-1 acts as a new tumor suppressor gene for different types of human cancer. More
This technology identifies twenty five (25) new alternatively spliced transcripts of the BORIS gene. More
Cripto-1 is overexpressed in infarcted myocardial tissue More
This technology describes several antibodies, both polyclonal and monoclonal, to the prolactin receptor. More
Use of cDNA microarrays to facilitate the identification of pulmonary neuroendocrine tumors More
Displaying 1..10 of 15 - per page Next page
Order by
Research Partnership for Due Diligence Execution
Pharmaceutical Antitrust
Industry news: Pharmalicensing provides comprehensive industry coverage.

© Copyright 1995-2008 Pharmalicensing Ltd, is a division of UTEK Corporation All rights reserved. Terms and Conditions | Site map | Contact us